Improving human quality of life with drug treatments is a complicated issue. Drug certification, including drug safety and reliability, entails a long series of tests and government approvals before the drug is available for anyone to use.
Spexis announces closing of sale of preclinical antibiotics program to Basilea – Biotech Investments
Spexis AG / Key word(s): Miscellaneous 08-Feb-2024 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely